Redefining Cardiovascular Risk Assessment as a Spectrum
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Universal Risk Prediction for Individuals With and Without Atherosclerotic Cardiovascular DiseaseJACC, 2024
- A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart AssociationCirculation, 2023
- When Does a Calcium Score Equate to Secondary Prevention?JACC: Cardiovascular Imaging, 2023
- Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithmEuropean Heart Journal, 2022
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trialsThe Lancet Diabetes & Endocrinology, 2021
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2021
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 DiabetesJAMA Cardiology, 2021
- Secondary Prevention for Atherosclerotic Cardiovascular DiseaseCirculation, 2020
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationCirculation, 2016